Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients

Affiliations

• 1 Department of Biochemistry, Faculty of Science, NCCR Chemical Biology, University of Geneva, Geneva, Switzerland.
• 2 Division of Endocrinology, Diabetes, Nutrition and Patient Education, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland.
• 3 Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• 4 Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• 5 Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
• 6 Department of Mathematics, University of Geneva, Geneva, Switzerland.
• 7 Department and Division of Primary Care Medicine, University Hospital of Geneva, Geneva, Switzerland.
• 8 Department of Digestive and Bariatric Surgery, Edouard Herriot University Hospital, University, Lyon, France.
• 9 CarMeN Laboratory, INSERM U1060, INRA 1397, University Lyon 1, Oullins, France.
• 10 Proteomics Core Facility, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
• 11 Gene Expression Core Facility, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
• 12 Division of Endocrinology, Diabetes, Nutrition and Patient Education, Department of Medicine, WHO Collaborating Centre, University Hospital of Geneva, University of Geneva, Geneva, Switzerland.
• 13 Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• 14 Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
• 15 INRA, Unité de Nutrition Humaine, Université Clermont Auvergne, Paris, France.